AIMI: AIM ImmunoTech Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) -3.86
Book Value / Share -0.05
Price / Book n/a
NCAV ($M) -7.52
NCAV / Share -0.10
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.94
Return on Equity (ROE) -3.15

Liquidity (mrq)
Quick Ratio 0.26
Current Ratio 0.26

Balance Sheet (mrq) ($M)
Current Assets 2.58
Assets 6.25
Liabilities 10.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.17
Operating Income -19.77
Net Income -17.32
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -14.89
Cash from Investing 4.71
Cash from Financing 6.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -22.64
12-23 13D/A Deutsch Todd 2.70 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
AGTX – Agentix Corp. AHRO – Authentic Holdings, Inc.
AIBT – Aibotics Inc. AKBLF – ALK-Abelló A/S
AMBS – Amarantus BioScience Holdings, Inc.


Financial data and stock pages provided by
Fintel.io